The Food and Drug Administration (FDA) announced a recall of the dietary supplements Oxyphen, Phentalene, Phen FX, and Red Vipers. According to the release from the FDA, the drugs carried with them the risk of elevating blood pressure which can lead to other cardiovascular problems.
Initiated on January 15, 2013, the recall applies to certain drugs containing dimethylamylamine (“DMAA”). In its release, the FDA warned that DMAA is a commonly-used stimulant that is potentially dangerous to an individual’s health. Further, the FDA announced that DMAA is not an ingredient recognized to be included in dietary supplements and therefore the drugs (Oxyphen, Phentalene, Phen FX, and Red Vipers) are not compliant with the Dietary Supplement Health and Education Act (DSHEA).
These drugs are distributed by Beta Labs, LTD; regularly sold via telephone. The FDA has advised that all consumers who have purchased the affected lots (Oxyphen XR lots 200910 and 20911, Phentalene lot 58800512, Phen FX lot 1205129, and Red Vipers lot 1205128) to discontinue using the products and contact their healthcare professionals should they experience adverse effects.
“When rushing a drug to market, companies will often overlook potential hazards in order to achieve profits. The voluntary recall from Beta Labs is an important step in preventing further exposure to these potentially dangerous drugs,” commented Daniel Nigh an attorney with the Levin, Papantonio law firm who practices in the area of pharmaceutical and bad drug litigation.
Individuals that have taken the drugs are encouraged to contact the company by email or telephone, 877-283-1742. Those that experienced an adverse reaction are encouraged to report it to the FDA via the FDA’s Medwatch Adverse Event Reporting program.
Joshua is a writer and researcher with Ring of Fire.
